On Saturday, people in parts of the United States, Canada, the Caribbean, Europe, Russia and Africa will get to experience a ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Pain in your eyes is unlikely to be a symptom of solar retinopathy, since the retina doesn’t have any pain receptors. The ...

The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...

The results suggest that IGC-AD1 may decrease the frequency and severity of sleep disturbances and night time behaviours.

IGC-AD1 Could Offer Safer Alternative to Existing Sleep Medications for Alzheimer’s - POTOMAC, MD / ACCESS Newswire / March ...

Integrated nicotine replacement and behavioral support at opioid agonist treatment clinics helped opioid-dependent patients reduce cigarette use.

IGC Pharma (IGC) announced additional interim results from its ongoing Phase 2 clinical trial on IGC-AD1, an investigational treatment for ...

One woman, Lucy, says she lost "a decade of her to life" to compulsive gambling and risky sex after being prescribed a partial dopamine agonist Patients prescribed drugs for movement disorders ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...